Literature DB >> 36214989

SARS-CoV-2 and Toxoplasma gondii shared symptoms suggest muscle cells and neurons are their chronic infection reservoirs.

Kevin Roe1.   

Abstract

Entities:  

Keywords:  Brain infections; Latent infections; Long COVID; SARS-CoV-2; Toxoplasma gondii

Year:  2022        PMID: 36214989      PMCID: PMC9549844          DOI: 10.1007/s13577-022-00809-y

Source DB:  PubMed          Journal:  Hum Cell        ISSN: 0914-7470            Impact factor:   4.374


× No keyword cloud information.
A significant percentage of COVID-19 patients experience extended duration Long COVID [1, 2]. Several symptoms have been exhibited in Long COVID patients, such as mental dysfunctions (e.g., cognitive dysfunction, altered mental status, mental confusion or behavioral changes), neurological deficits (which along with depression, anxiety, memory and attention deficiencies, sleep disorders may alternatively be classified under mental dysfunctions), movement abnormalities (e.g., involuntary movements or ataxia/incoordination), fatigue, fever, dyspnea (labored breathing), myalgia (muscle pain), arthralgia (joint pain), tinnitus (ear ringing), vertigo (dizziness), otalgia (earache), anosmia (impaired smell), dysgeusia (impaired taste), speech and swallowing deficits and hair loss [1-4]. The primary aim of this letter is discuss some considerable similarities between the symptoms of Long COVID and the symptoms resulting from infections by the protozoan parasite Toxoplasma gondii. Table 1 provides a comparison of several potential symptoms that can result from infections by these pathogens.
Table 1

Compares the symptoms of Long COVID/PASC and T. gondii infections

The Major Exhibited Symptoms of Long COVID/PASC Compared to Infect. by T. gondii
Exhibited Symptoms1Long COVIDT. gondiiAlternative Category Or Possible Causation
Mental Dysfunctions2ObservedObservedcognitive dysfunction,
altered mental status,
mental confusion or
behavioral changes
Neurological DeficitsObservedObservedmental dysfunctions?
DepressionObservedPossiblea mental dysfunction?
AnxietyObservedPossiblea mental dysfunction?
Sleep DisordersObservedPossiblea mental dysfunction?
Movement Abnormalities3ObservedObservedinvoluntary moves or
ataxia/incoordination
FatigueObservedObservedfrom chronic infection?
FeverObservedObservedfrom chronic infection?
Hair lossObservedPossiblefrom chronic infection?
Dyspnea/Labored breathObservedObservedfrom muscle cell infection?
Myalgia/Muscle pain ObservedPossiblefrom muscle cell infection?
Arthralgia/Joint painObservedPossiblefrom joint/muscle cell infection?
Tinnitus/Ear ringingObservedPossiblecranial nerve infection
Otalgia/EaracheObservedPossiblecranial nerve infection
Vertigo/DizzinessObservedPossible cranial nerve infection
Anosmia/Impaired smellObservedPossiblecranial nerve infection
Dysgeusia/Impaired tasteObservedPossiblecranial nerve infection
Speech & Swallow DeficitsObservedPossiblecranial nerve infection

1[Refs 1–6]

2Mental dysfunctions include cognitive dysfunction, altered mental status, mental confusion or behavioral changes, neurologic deficits are perhaps a duplicated category; depression and anxiety could also be duplicated categories of mental dysfunctions

3Movement abnormalities include involuntary movements and ataxia/incoordination

Compares the symptoms of Long COVID/PASC and T. gondii infections 1[Refs 1–6] 2Mental dysfunctions include cognitive dysfunction, altered mental status, mental confusion or behavioral changes, neurologic deficits are perhaps a duplicated category; depression and anxiety could also be duplicated categories of mental dysfunctions 3Movement abnormalities include involuntary movements and ataxia/incoordination Several Long COVID neurological symptoms could potentially be explained by cranial nerve (C.N.) infections affecting the functions of the 12 cranial nerves [4-6]. Another paper has proposed a link between Long COVID and the SARS-CoV-2 full spike protein through induced neuroinflammation [7]. Additionally, a study of SARS-CoV-2 antigens and cytokines from plasma samples extracted from 63 adults previously infected by SARS-CoV-2, including 37 adults diagnosed to have Long COVID/post-acute sequelae of COVID-19 (PASC), detected the SARS-CoV-2 full spike protein in 60% of individuals exhibiting Long COVID/PASC symptoms up to 12 months past their COVID-19 diagnosis [8]. This suggested to the researchers that there is a viral chronic infection reservoir for SARS-CoV-2, causing Long COVID/PASC in at least 60% of the cases [8]. However, the S1 and N proteins of SARS-CoV-2 were detected in fewer individuals and several inflammatory cytokine blood plasma levels were inconclusive [8]. The researchers hypothesized a viral reservoir of chronic infection and suggested that since Long COVID/PASC is a heterogeneous syndrome, that this could depend on the viral reservoir tissue location [8]. This raises several questions: (1) is there a viral reservoir causing 60% of the Long COVID/PASC cases, (2) where is the viral reservoir located and (3) are there are other pathways without a viral reservoir for the other 40% of the Long COVID/PASC cases? The virus SARS-CoV-2 is not the only pathogen capable of chronic infections exhibiting numerous neurological and psychological symptoms. Protozoan parasites, including Toxoplasma gondii, cause chronic infections which in some cases can exhibit neurological and psychological symptoms that almost parallel Long COVID/PASC [6]. Since these pathogens are pervasive and adept intracellular pathogens, it is plausible that SARS-CoV-2 and T. gondii could in some cases use central nervous system neurons and/or muscle cells as chronic infection reservoirs. This could also explain the major similarities in these pathogens regarding the symptoms observed during their potentially chronic infections. Long COVID/PASC symptoms also extensively match many of the symptoms caused by a partially or fully reactivated T. gondii infection [6]. Individuals infected by T. gondii can exhibit an extensive number of neurological and muscular symptoms, such as altered mental status, focal neurological deficits, mental confusion, cognitive dysfunction, ataxia, behavioral or psychomotor changes, involuntary movements, dyspnea, fevers, seizures, headaches, changes in vision, pneumonia, chorioretinitis and various cranial nerve infections [4, 6]. T. gondii has a documented capability to maintain chronic infections in muscles cells and central nervous system neurons with intracellular bradyzoite cysts [6]. Intracellular infections of cells typically lead to pathogen antigen presentation by the infected cells to CD8 T cells to induce cytotoxic CD8 T cell attacks to limit cellular infections [6]. However, neurons are known to be immuno-privileged to minimize damage from inflammation and other immune responses [9]. In addition, quiescent muscle cells, such as muscle stem cells, are also immuno-privileged with downregulated antigen presentation [10]. Therefore, some adept pathogens would seek to evolve means to evade or disable CD8 T cells, such as T. gondii's use of metabolically inactive bradyzoite cysts in neurons and muscle cells, to evade cytotoxic attack by CD8 T-cells and maintain chronic infections [6]. Such chronic infections of neurons by T. gondii cysts can also potentially disrupt brain levels of neurotransmitters including glutamate, gamma-aminobutyric acid (GABA), and dopamine [6]. These disruptions can explain why latent T. gondii infections in some cases are linked to an extensive number of brain-associated disorders [6]. Coronaviruses, including the SARS-CoV-2 virus, can in some cases penetrate the blood–brain barrier (BBB), and/or utilize a neuronal pathway via sensory nerves (e.g., the olfactory nerve) or motor nerve endings [6]. The extent of transport of SARS-CoV-2 into the brain via the BBB or nerve pathways, can cause different infection pathways and consequences, and could potentially explain why Long COVID/PASC has widely varying sets of observed symptoms among individuals. There may also be other pathways without a chronic infection viral reservoir that could explain the remaining Long COVID/PASC cases that lack SARS-CoV-2 antigens. In conclusion, the post-infection symptoms of Long COVID/PASC are sometimes experienced after active SARS-CoV-2 virus infections. Long COVID/PASC exhibits several neurological and muscular symptoms that substantially parallel T. gondii infection symptoms. T. gondii is known to use central nervous system neurons and muscle cells to maintain chronic infections. It is therefore plausible that in some cases SARS-CoV-2 and T. gondii both use central nervous system neurons and muscle cells as reservoirs to maintain chronic infections. There may also be other pathways without a chronic infection viral reservoir that could explain the remaining Long COVID/PASC cases that lack SARS-CoV-2 antigens.
  10 in total

Review 1.  Guidelines for radiographic imaging of cranial neuropathies.

Authors:  Aliasgher Khaku; Vijay Patel; Thomas Zacharia; David Goldenberg; Johnathan McGinn
Journal:  Ear Nose Throat J       Date:  2017 Oct-Nov       Impact factor: 1.697

2.  Quiescent Tissue Stem Cells Evade Immune Surveillance.

Authors:  Judith Agudo; Eun Sook Park; Samuel A Rose; Eziwoma Alibo; Robert Sweeney; Maxime Dhainaut; Koichi S Kobayashi; Ravi Sachidanandam; Alessia Baccarini; Miriam Merad; Brian D Brown
Journal:  Immunity       Date:  2018-02-20       Impact factor: 31.745

3.  Persistent circulating SARS-CoV-2 spike is associated with post-acute COVID-19 sequelae.

Authors:  Zoe Swank; Yasmeen Senussi; Zachary Manickas-Hill; Xu G Yu; Jonathan Z Li; Galit Alter; David R Walt
Journal:  Clin Infect Dis       Date:  2022-09-02       Impact factor: 20.999

4.  One year on: an updated systematic review of SARS-CoV-2, COVID-19 and audio-vestibular symptoms.

Authors:  Ibrahim Almufarrij; Kevin J Munro
Journal:  Int J Audiol       Date:  2021-03-22       Impact factor: 2.117

Review 5.  Toxoplasma gondii infection and its implications within the central nervous system.

Authors:  Sumit K Matta; Nicholas Rinkenberger; Ildiko R Dunay; L David Sibley
Journal:  Nat Rev Microbiol       Date:  2021-02-24       Impact factor: 60.633

Review 6.  Postacute COVID-19: An Overview and Approach to Classification.

Authors:  Eva M Amenta; Amy Spallone; Maria C Rodriguez-Barradas; Hana M El Sahly; Robert L Atmar; Prathit A Kulkarni
Journal:  Open Forum Infect Dis       Date:  2020-10-21       Impact factor: 3.835

7.  Follow-up of adults with noncritical COVID-19 two months after symptom onset.

Authors:  Claudia Carvalho-Schneider; Emeline Laurent; Adrien Lemaignen; Emilie Beaufils; Céline Bourbao-Tournois; Saïd Laribi; Thomas Flament; Nicole Ferreira-Maldent; Franck Bruyère; Karl Stefic; Catherine Gaudy-Graffin; Leslie Grammatico-Guillon; Louis Bernard
Journal:  Clin Microbiol Infect       Date:  2020-10-05       Impact factor: 8.067

8.  Long COVID-19-it's not over until?

Authors:  Dana Yelin; Ili Margalit; Dafna Yahav; Michael Runold; Judith Bruchfeld
Journal:  Clin Microbiol Infect       Date:  2020-12-11       Impact factor: 8.067

Review 9.  Could SARS-CoV-2 Spike Protein Be Responsible for Long-COVID Syndrome?

Authors:  Theoharis C Theoharides
Journal:  Mol Neurobiol       Date:  2022-01-13       Impact factor: 5.682

Review 10.  The Symptoms and Clinical Manifestations Observed in COVID-19 Patients/Long COVID-19 Symptoms that Parallel Toxoplasma gondii Infections.

Authors:  Kevin Roe
Journal:  J Neuroimmune Pharmacol       Date:  2021-05-29       Impact factor: 4.147

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.